FDA Eliminates Clozapine REMS Program: What This Means for Patients and Prescribers
In a major regulatory update, the U.S. Food and Drug Administration (FDA) has announced the discontinuation of the Risk Evaluation and Mitigation Strategy (REMS) program…
